DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Pheniramine is an investigational drug.
There have been 33 clinical trials for Pheniramine. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2011.
The most common disease conditions in clinical trials are Rhinitis, Rhinitis, Allergic, and Common Cold. The leading clinical trial sponsors are Mantecorp Industria Quimica e Farmaceutica Ltd., EMS, and National Cancer Center, Korea.
There is one US patent protecting this investigational drug and eleven international patents.
Recent Clinical Trials for Pheniramine
|Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative Endoscopy||Seoul National University Hospital||N/A|
|Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical Research||China Medical University Hospital||N/A|
|Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine||Mahidol University||Phase 4|
Top disease conditions for Pheniramine
Top clinical trial sponsors for Pheniramine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pheniramine||See Pricing||Heterocyclic compounds useful in the treatment of disease||Epigen Biosciences, Inc. (San Diego, CA)||See Pricing|
|Pheniramine||See Pricing||Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof||See Pricing|
|Pheniramine||See Pricing||Ultra-pure agonists of guanylate cyclase C, method of making and using same||SYNERGY PHARMACEUTICALS, INC. (New York, NY)||See Pricing|
|Pheniramine||See Pricing||Compositions containing polymeric, ionic compounds comprising imidazolium groups||BASF SE (Ludwigshafen, DE)||See Pricing|
|Pheniramine||See Pricing||Drug combinations and uses in treating a coughing condition||Infirst Healthcare Limited (London, GB)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|